Navigation Links
VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
Date:9/24/2008

se 2 clinical trial, the FDG-PET Trial. Enrollment in this trial is ongoing and endpoints in this study include reduction in carotid plaque inflammation following dosing with VIA-2291 as measured with state-of-the-art FDG-PET imaging technology, as well as assessment of standard biomarker measurements of inflammation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Company plc ("Perrigo") (NYSE: PRGO ; TASE) today ... the unsolicited Proposal (the "Proposal") from Mylan NV ("Mylan") ... acquire all of the outstanding shares of Perrigo for ... its financial and legal advisors, the Board unanimously concluded ... future growth prospects and is not in the best ...
(Date:4/21/2015)... April 21, 2015 EpiCast Report: Sepsis - ... is a life-threatening complication arising from an infection; it ... its own tissues and organs. Anyone can develop sepsis; ... <1 year of age, older adults, and those ... for the year 2013 showed that there are around ...
(Date:4/21/2015)... 21. April 2015  CorTechs Labs, der ... Analyse des Hirnvolumens freut sich, eine Partnerschaft ... bekannt geben zu können. Die Unternehmen werden ... Hirnvolumens zusammenarbeiten, der die Identifizierung, Messung und ... mit multipler Sklerose als Ziel hat. ...
Breaking Medicine Technology:Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 2Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 4Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 5Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 6Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 7Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 8Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 9EpiCast Report: Sepsis - Epidemiology Forecast to 2023 2EpiCast Report: Sepsis - Epidemiology Forecast to 2023 3CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... Lynch Health Care Conference on Thursday, May 12, 2011 at ... Interested parties may access a live webcast of the ... It is recommended that listeners log on ...
... American Regent announced today that it had resumed the ...  Release of products is being prioritized and American Regent is ... that supplies of critically needed medications are available for patient ... are available from your local Wholesaler or Distributor. ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2American Regent Resumes Shipment of Injectable Products 2
(Date:4/21/2015)... Wireless Analytics, LLC , a pioneering provider ... Boston Business Journal as the 25th fastest-growing private company ... recent event celebrating the 2015 Pacesetters, the Boston ... in Massachusetts. , Wireless Analytics was ranked among 70 ... fastest revenue growth from 2011 through 2014. This ...
(Date:4/21/2015)... Lowcostcarinsuranceprice.com has released a new blog post explaining how ... , SUVs are large vehicles that fare well in ... a smaller regular car shows that passengers from the first ... safer in crashes, but these large vehicles may be unstable ... It is now possible to find low cost car insurance ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... report strengthens R&D pipelines by identifying new ... best-in-class products. Complete report with TOC is ... The report also reviews key players involved ...
(Date:4/21/2015)... has released a new blog post presenting heavily circulated ... insurance prices . , Commuting on heavy circulated ... their insurance options before deciding what plan to buy. ... of the popular policies provide liability, collision or comprehensive ... find the best prices in their area simply by ...
(Date:4/21/2015)... 21, 2015 Edward Avalos, USDA Under ... Kawamura, former Secretary of the California Department of Food ... the 2nd Annual GrowRIVERSIDE Conference: The Future of Local ... inclusion of these nationally known experts intensifies an already ... farmers and others slated to speak at the June ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3
... 12 To commemorate National,Nursing Home Week (May ... Epidemiology (APIC) is issuing five steps every,resident and ... advocate and reduce,the risk of developing an infection ... learn more., 1) First Step, Infection Prevention ...
... 750,000, mostly males, are hooked , , MONDAY, May 12 ... young adults are problem gamblers according to researchers at ... , Problem gambling is defined as gambling associated with ... than you intended or stealing money to gamble. , ...
... "Vision is important,in childhood learning, and vision care ... Karla Zadnik, OD, PhD, Associate Dean,of The Ohio State ... local eye doctors throughout Ohio present "The,Adventures of Rhet ... in their community. Using the puppets Rhet and Tina ...
... 12 Target Data Research (TDR) was,recently recognized ... annual Step,N,Forward fundraising campaign. TDR joined forces with ... American Elder Care, Comfort,Keepers and the Tampa Police ... Solutions efforts for this year., Aging Solutions, ...
... Juice Superfood Smoothie Line has ,Lifeguard(TM) ... ... is proud to,introduce a new line of all natural 100% juice ... added nutritional,benefits of "Lifeguard(TM) Protection," a fortification package of,essential vitamins, nutrients, ...
... May 12 Marie Shouldice, RN, sees,herself as a ... 28 years it,s been her passion, and when she ... health advocate,accredited by Berkeley, CA-based Healthcare Liaison., "For ... angst,that people encounter in the process of navigating the ...
Cached Medicine News:Health News:APIC Recommendations on Infection Prevention in Long-Term Care Facilities 2Health News:Problem Gambling Common Among Young Adults 2Health News:Students Focus on Vision 2Health News:New Sun Shower(TM) Superfood Smoothies 2Health News:New Sun Shower(TM) Superfood Smoothies 3Health News:Retiring Nurses See Healthcare Advocacy as Second Career - Healthcare Liaison Workshop June 7-8 Shows Them How to Make Transition 2
The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
The K-ASSAY Fibrinogen Control is an assayed quality control material intended for use in monitoring the accuracy and precision of the quantitative determination of fibrinogen....
Rapid test for mononucleosis...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
Medicine Products: